Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
electroCore Inc
ECOR | US
7.52
USD-0.46
-5.71%
ECOR | US
About electroCore Inc
Sector
Healthcare
Industry
Medical Devices
Earnings date
30/06/2024
As of date
05/03/2026
Close
7.52
Open
7.81
High
8.21
Low
7.13
electroCore Inc. a commercial-stage bioelectronic medicine and wellness company engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults; Truvaga for the support of general health and wellbeing; and TAC-STIM a form of nVNS for human performance. Its lead product is gammaCore Sapphire a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway New Jersey.
View LessECOR | US
Risk
89.4
Sharpe
-0.59
Luna's Score
52/100
Recommendation
Hold
Luna says (ECOR | US)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
66.4%1 month
89.4%3 months
82.3%6 months
75.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.52
Debt to equity
0.35
Debt to assets
0.18
Ent. to EBITDA
0.16
Ent. to rev.
1.95
PEG
-
Other Fundamentals
EBITDA
-13.47M
MarketCap
48.48M
MarketCap(USD)
48.48M
Div. yield
-
Op. margin
-42.21
Erngs. growth
-
Rev. growth
72.90
Ret. on equity
-153.49
Short ratio
1.22
Short perc.
0.63
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
2.35
Range1M
3.14
Range3M
3.89
Volumes: Market Activity
Rel. volume
0.91
Price X volume
343.55K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.16 | - | Cheaper |
| Ent. to Revenue | 1.95 | - | Cheaper |
| PE Ratio | - | 30.41 | - |
| Price to Book | 4.52 | 6.21 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 82.32 | - | Riskier |
| Debt to Equity | 0.35 | -145.53 | Expensive |
| Debt to Assets | 0.18 | 0.35 | Cheaper |
| Market Cap | 48.48M | - | Emerging |
